Full approval is crucial for Novavax to proceed with a $175m partnership deal with Sanofi, set to commence in the 2025-2026 ...
Dr. Christopher J. Sayed shares insights on the growing emphasis on personalized care for hidradenitis suppurativa.
Dupixent approved as the first-ever biologic medicine in Japan for patients with COPD Following recent approvals in the EU, China, and the US, this approval was based on pivotal phase 3 results ...
Press Release: Dupixent approved as the first-ever biologic medicine in Japan for patients with COPD
Dupixent approved as the first-ever biologic medicine in Japan for patients with COPDFollowing recent approvals in the EU, China, and the US, ...
Sanofi is listed on EURONEXT ... the pending civil proceedings initiated or joined by the U.S. Department of Justice and the U.S. Attorney's Office for the District of Massachusetts), risks associated ...
Varied approaches to remote patient monitoring are in development to close care gaps between patients and rheumatologists, ...
"I think we were contrarians,” Sanofi's chief digital officer Emmanuel Frenehard told Fortune. “I think the contrarians are ...
Sanofi said it would acquire Bispecific Myeloid Cell Engager, an autoimmune disease treatment, from Dren Bio, for up to $1.9 billion. The French pharmaceutical company on Thursday said it would ...
Sanofi is increasing focus on innovative medicines while moving away from consumer health. Image credit: Shutterstock/Below the Sky. Sanofi is continuing its immunology pipeline push with an agreement ...
The Dren Bio therapy is part of a growing trend of research into autoimmune disease medicines that can reset the immune system instead of suppressing it. The work is built on promising results in ...
The deal is the latest in a series of Sanofi investments in its immunology portfolio. According to Sanfoi, DR-0201 can achieve deep B cell depletion, giving it the potential to reset the immune system ...
We list the best free office software, to make it simple and easy to try something different to Microsoft, but without having to pay for a license. However, over the years other companies have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results